Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer.

Kobayashi Y, Kashima H, Rahmanto YS, Banno K, Yu Y, Matoba Y, Watanabe K, Iijima M, Takeda T, Kunitomi H, Iida M, Adachi M, Nakamura K, Tsuji K, Masuda K, Nomura H, Tominaga E, Aoki D.

Oncotarget. 2017 Aug 7;8(42):72147-72156. doi: 10.18632/oncotarget.20046. eCollection 2017 Sep 22.

2.

Correction: N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion.

Lane DJ, Saletta F, Rahmanto YS, Kovacevic Z, Richardson DR.

PLoS One. 2016 Feb 25;11(2):e0149922. doi: 10.1371/journal.pone.0149922. eCollection 2016. No abstract available.

3.

Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis.

Guan B, Rahmanto YS, Wu RC, Wang Y, Wang Z, Wang TL, Shih IeM.

J Natl Cancer Inst. 2014 Jun 4;106(7). pii: dju146. doi: 10.1093/jnci/dju146. Print 2014 Jul.

4.

Hepcidin bound to α2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels.

Huang ML, Austin CJ, Sari MA, Rahmanto YS, Ponka P, Vyoral D, Richardson DR.

J Biol Chem. 2013 Aug 30;288(35):25450-65. doi: 10.1074/jbc.M113.471573. Epub 2013 Jul 11.

Supplemental Content

Loading ...
Support Center